Notably, IgE levels had increased by 230% compared to pre-treatment values, a percentage higher than the cohort average and closer to that reported by Vennera MDC et al. in patients who did not maintain good asthma control (median increase of 256%) (20). The gene discussed is IGHE; the disease is asthma.